Volume 29


Special Issue 1 (in Progress)
Resistance and Therapy Failure in Eye cancer



PD Dr. Vinodh Kakkassery & Prof. Dr. med. Ludwig Heindl (Editors)


Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab

Kakkassery V., Heindl L., Rokohl A., Chronopoulos A., Schutz J., Ranjbar M., Schargus M., Böker A., Winterhalter S., Stübiger N.

Neurosignals 2021;29(S1):1-7

HTML PDF https://doi.org/10.33594/000000367